STOCK TITAN

Millennium-linked holders report 6.5% Cryoport (CYRX) ownership

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Cryoport, Inc. has a new large shareholder disclosure. Investment entities Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of about 3.2 million shares of Cryoport common stock, representing 6.5% of the outstanding class as of December 31, 2025.

The reporting parties state they share voting and dispositive power over these shares and certify the position was not acquired to change or influence control of Cryoport, but instead is held on a passive basis under Schedule 13G rules.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Integrated Core Strategies (US) LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/04/2026
Millennium Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/04/2026
Millennium Group Management LLC
Signature:/s/ Gil Raviv
Name/Title:Gil Raviv, Global General Counsel
Date:02/04/2026
Israel A. Englander
Signature:/s/ Israel A. Englander
Name/Title:Israel A. Englander
Date:02/04/2026

Comments accompanying signature: ** INTEGRATED CORE STRATEGIES (US) LLC By: Integrated Holding Group LP, its Managing Member By: Millennium Management LLC, its General Partner
Exhibit Information

Exhibit I: Joint Filing Agreement, dated as of February 4, 2026, by and among Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander.

FAQ

What stake in Cryoport (CYRX) is reported in this Schedule 13G/A?

The filing reports beneficial ownership of 3,244,802 shares of Cryoport common stock, representing 6.5% of the outstanding class as of December 31, 2025, by Millennium-related entities and Israel A. Englander.

Who are the reporting persons in Cryoport (CYRX) Schedule 13G/A Amendment No. 1?

The reporting persons are Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, who together report shared voting and dispositive power over the disclosed Cryoport common stock position.

Is the Cryoport (CYRX) 6.5% position filed as a passive investment?

Yes. The signatories certify the Cryoport securities were not acquired and are not held for the purpose of changing or influencing control of the issuer, consistent with a passive ownership filing under Schedule 13G requirements.

What voting and dispositive powers are disclosed for the Cryoport (CYRX) shares?

The filing shows zero sole voting or dispositive power and 3,244,802 shares with shared voting and shared dispositive power, reflecting that control over the Cryoport position is exercised jointly among the reporting entities.

When did the ownership event for this Cryoport (CYRX) Schedule 13G/A occur?

The date of the event requiring the filing is stated as December 31, 2025, meaning the 6.5% beneficial ownership level in Cryoport common stock was reached or present as of that date.

Who signed the Cryoport (CYRX) Schedule 13G/A on behalf of the reporting entities?

Gil Raviv, Global General Counsel, signed for Integrated Core Strategies (US) LLC, Millennium Management LLC and Millennium Group Management LLC, while Israel A. Englander signed in his own name, each certifying the accuracy of the ownership information provided.
Cryoport Inc

NASDAQ:CYRX

CYRX Rankings

CYRX Latest News

CYRX Latest SEC Filings

CYRX Stock Data

430.59M
48.07M
3.82%
100.71%
5.44%
Integrated Freight & Logistics
Pharmaceutical Preparations
Link
United States
BRENTWOOD